Medline has been tapped as the exclusive provider of medical and surgical supplies for Boston-based Mass General Brigham’s healthcare network, including for its ASCs.
Category: Supply Chain
Mass General Brigham switches supply vendors
Boston-based Mass General Brigham tapped Medline on Feb. 27 as its strategic medical supply vendor.
10 months later, GE's contrast dye nears normal supply levels
GE Healthcare said Feb. 23 it expects its contrast media products, which are used in CT scans and fell into shortage in May 2022, will return to normal supply levels in the next few weeks.
FDA warns of infant incubators with possible airborne chemical risk
Neonatal incubators may be exposing people to “volatile chemicals,” the FDA warned healthcare workers Feb. 23.
Pennsylvania system taps yearslong lab supplier
West Reading, Pa.-based Tower Health is looking to strengthen its laboratory supply chain with a new partnership with Quest Diagnostics, the two companies said Feb. 16.
GE recalls body scanners over risk of trapping, crushing patients
GE HealthCare issued a recall of 688 of its Nuclear Medicine 600/800 Series Systems after identifying an issue that could lead to the machine’s detector falling and trapping or crushing a patient. In a Feb. 15 statement, the FDA classified this as a Cl…
Drug shortages up 30% and 10 more supply chain updates this week⎮2023
Here are the supply chain updates ASC leaders need to know this week.
CFOs' biggest financial threat to healthcare and 9 more supply chain updates
Here are 10 supply chain updates for ASC leaders reported by Becker’s since Feb. 3:
Inflation pressure persists in the US supply chain
Warehouse and distribution center storage prices are up 11 percent year over year, putting more pressure on the U.S. supply chain and consumer costs, according to a Feb. 13 report from CNBC.
Shot-down Chinese balloon may affect US medical supply chain
After the U.S. shot down a “high-altitude object” hovering above Alaska’s waters on Feb. 10 and a confirmed Chinese spy balloon the week prior, it’s unclear what these actions mean for the U.S.-China medical supply chain.
